• Articles

    Up-Front Palliative Care Consultation Associated With Better Outcomes in Advanced Cancer
  • Articles

    FDA Grants Regular Approval to Blinatumomab and Expands Indication to Include Philadelphia Chromosome-Positive B Cell ALL
  • Articles

    ONS Answers Your Top Questions About Cancer Immunotherapy
  • Articles

    FDA Approves Neratinib for Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer
  • Articles

    The Case of the Immunotherapy Inquiry, Part II
  • Articles

    Walls and a Blue Ribbon
  • Articles

    Who Is Monitoring Your Infusions for Administration Safety?
  • Articles

    Management of Immunotherapy-Related Endocrinopathies
  • Articles

    Symptom Distress in Patients With Hepatocellular Carcinoma Toward the End of Life
  • Articles

    Adherence and Coping Strategies in Outpatients With Chronic Myeloid Leukemia Receiving Oral Tyrosine Kinase Inhibitors